100 mg Aspirin Twice Daily Non-Inferior to Once Daily 10 mg Rivaroxaban for Prevention of VTE in THA
How to Cite
OrthoEvidence. 100 mg Aspirin Twice Daily Non-Inferior to Once Daily 10 mg Rivaroxaban for Prevention of VTE in THA. ACE Report. 2021;10(2):36. Available from: https://myorthoevidene.com/AceReport/Report/13116
Comparable efficacy of 100 mg aspirin twice daily and rivaroxaban for venous thromboembolism prophylaxis following primary total hip arthroplasty: a randomized controlled trialChin Med J (Engl). 2021 Jan 5;134(2):164-172.
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Seventy-eight patients undergoing a unilateral total hip arthroplasty (THA) were randomized in this non-inferiority trial to receive 5 weeks of aspirin (100 mg twice per day; n=37) or 5 weeks of rivaroxaban (10 mg once per day) post-operation for the prevention of deep vein thrombosis (DVT). The primary outcome of interest was the incidence of DVT which was assessed using Doppler ultrasonography a...
Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.LEARN MORE